Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Explore well-known S&P 500 index funds for retirement 2024, focusing on performance, costs, and suitability for your plan.
22,695 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
First-quarter 2026 saw a record pace of home equity withdrawals as borrowers leaned on second liens and HELOCs rather...
A hypothetical SpaceX IPO could unlock exciting (and risky) gains for a $5,000 stake. This guide walks through the ma...
Could mercadolibre stock headed $2,800? be more than a headline. This deep dive examines growth drivers, risks, and h...
When a board member snaps up thousands of shares as the stock falls, it sparks questions. This piece breaks down what...
As employers rethink wellness benefits, workers weigh B12's energy promise against testing costs and coverage gaps, s...
As AI accelerates, two chipmakers stand out for very different reasons. This analysis weighs whether broadcom stock b...
A new crypto ETF offering 2x daily exposure to a Bitcoin strategy has collapsed, leaving early investors with severe ...
Brazilian officials say May deforestation hit a record low, even as the U.S. weighs new tariffs. The so-called 'trump...
The latest pullback in software-as-a-service stocks may feel painful, but it also creates patient-buying opportunitie...
MicroStrategy’s small BTC disposal drew sharp commentary as bitcoin tests new price ranges. Industry voices argue the...
Alphabet stock already fuels your tech exposure. If SpaceX goes public, should spacex after already owning Alphabet b...